High Risk of Recurrence of Malignancy Noted in 4-day rATG Regimen after Allogeneic PBSCT from Matched Sibling Donors.

Nan Wang,Haitao Wang,Shu Fang,Jishan Du,Sai Huang,Fei Li,Xiangshu Jin,Mingyu Jia,Lingmin Xu,Liping Dou,Daihong Liu

Transplantation and cellular therapy（2022）

引用 0|浏览6

暂无评分

摘要

High CIR and worse DFS were noted in MSD-PBSCT receiving 4d-ATG regimen compared with historical control (2d-ATG regimen). Inappropriate rATG timing may increase the risk of relapse after MSD-PBSCT in patients with hematologic malignancies.

查看译文

关键词

ATG,Graft-versus-host disease,Peripheral blood,Relapse,Stem cell transplantation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要